Mutual Funds & ETF's
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
NYSE COMPOSITE INDX
Anthera Pharmaceuticals To Submit Trial Protocols
MarketMinute.com Stock News
Posted on September 18, 2012 at 14:19 PM EDT
Anthera Pharmaceuticals Inc. (
) will submit Phase 3 trial protocols for its lupus treatment blisibimod lifting the stock price 13 cents to $1.18.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Terms and Conditions
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Bots go here